pivalyloxymethyl butyrate has been researched along with Neoplasm Metastasis in 2 studies
*Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviram, A; Nudelman, A; Rabizadeh, E; Rephaeli, A; Ruse, M; Shaklai, M; Zimrah, Y | 1 |
| Entin-Meer, M; Hass-Kogan, D; Inbal, A; Nudelman, A; Rephaeli, A; Tarasenko, I; Tarasenko, N | 1 |
2 other study(ies) available for pivalyloxymethyl butyrate and Neoplasm Metastasis
| Article | Year |
|---|---|
Novel anticancer prodrugs of butyric acid. 2.
Topics: Animals; Antineoplastic Agents; Butyrates; Cell Differentiation; Cell Division; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Neoplasm Metastasis; Prodrugs; Tumor Cells, Cultured | 1992 |
Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex).
Topics: Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents; Butyrates; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neoplasm Metastasis; Organophosphorus Compounds; PTEN Phosphohydrolase; Tissue Inhibitor of Metalloproteinase-1 | 2008 |